» Articles » PMID: 29700802

Acute and Chronic Effects of Metabolic Acidosis on Renal Function and Structure

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2018 Apr 28
PMID 29700802
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Emerging evidence suggests that chronic metabolic acidosis (CMA) may have significant implications in terms of worsening renal disease in CKD patients, but the effect of CMA on renal function and structure has not been fully elucidated.

Method: We studied the acute and chronic consequences of an acid load (AL) on glomerular filtration rate (GFR) and renal histology in C57BL/6 mice. FITC-inulin clearance was performed at several time points; markers of renal fibrosis were studied at mRNA and protein levels; finally, kidney expression of candidate molecules triggering changes in renal function was studied.

Results: Glomerular hyperfiltration occurred within 1-3 days from AL; after 1 week, the GFR returned to baseline and then declined progressively within 15-21 days. The GFR decline was accompanied by the onset of renal fibrosis, as shown by Masson trichrome staining. Markers of renal fibrosis, namely α-smooth muscle actin and collagen-1, increased after 1 day of acid loading in both mRNA and protein levels and remained higher than baseline for up to 21 days. Well-known mediators of renal fibrosis, including transforming growth factor (TGF)-β and the intrarenal renin-angiotensin system (RAS) axis, were increased even before the decline of the GFR.

Conclusion: Acid load caused hyperfiltration acutely and a progressive decline of the GFR chronically; the evidence of renal fibrosis indicates that structural and not only functional renal changes occurred. The concomitant upregulation of TGF-β and intrarenal RAS axis indicates that those factors may be potentially involved in the progression of kidney disease in this setting.

Citing Articles

Metabolic acidosis in anaesthesia and critical care.

Park M, Cave G, Freebairn R BJA Educ. 2024; 24(3):91-99.

PMID: 38375495 PMC: 10874758. DOI: 10.1016/j.bjae.2023.12.005.


Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.

Adamczak M, Surma S Kidney Dis (Basel). 2021; 7(6):452-467.

PMID: 34901192 PMC: 8613635. DOI: 10.1159/000516371.


Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin.

Bovee D, Janssen J, Zietse R, Danser A, Hoorn E Nephrol Dial Transplant. 2020; 35(10):1821-1823.

PMID: 32710099 PMC: 7538238. DOI: 10.1093/ndt/gfaa136.

References
1.
Capobianco V, Caterino M, Iaffaldano L, Nardelli C, Sirico A, Del Vecchio L . Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity. Sci Rep. 2016; 6:25270. PMC: 4850482. DOI: 10.1038/srep25270. View

2.
Ponticelli C, Cucchiari D . Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment. J Nephrol. 2017; 30(2):155-157. DOI: 10.1007/s40620-017-0378-x. View

3.
Kraut J, Madias N . Consequences and therapy of the metabolic acidosis of chronic kidney disease. Pediatr Nephrol. 2010; 26(1):19-28. PMC: 2991191. DOI: 10.1007/s00467-010-1564-4. View

4.
Caso G, Garlick P . Control of muscle protein kinetics by acid-base balance. Curr Opin Clin Nutr Metab Care. 2004; 8(1):73-6. DOI: 10.1097/00075197-200501000-00011. View

5.
Krieger N, Frick K, Bushinsky D . Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens. 2004; 13(4):423-36. DOI: 10.1097/01.mnh.0000133975.32559.6b. View